ARCHIVES

Banned Investigator Plans To Resume Clinical Trials Role

This article is from The Cancer Letter archive.

Vol. 16 No. 32 | August 10, 1990

Download PDF Visit The Full Archive

Related Articles

NCCTG Plans To Conduct Phase II Study Of Brostallicin Plus Cisplatin For mTNBC

April 30, 2010

13th Congress Advance Program Announcement Now Available

May 1, 1981

Argentine Human Rights Violations Continue, But Some Improvement Seen

October 20, 1978

NCI To Pilot Text Chat On CancerNet And CIS Sites.

September 29, 2000

Phase III Regorafenib Trial Meets PFS Primary Endpoint

June 29, 2012

Oxford University Press Wins CRADA For Journal Of The National Cancer Istitute

September 20, 1996